86 European, US children down with severe hepatitis; experts perplexed

Some have cited COVID-19 as a reason; some two years of it, while the rest have blamed the adenovirus

This is why Hepatitis B, Hepatitis C are dangerous

Just one in 10 infected know their status and many are unaware that the inflamation of the liver is a common and treatable disease

Access to viral hepatitis diagnosis and treatment is still limited: WHO

In Africa, less than eight countries provide subsidised testing and treatment for viral hepatitis

Three win Nobel Prize in medicine for discovery of Hepatitis C virus

Harvey J Alter, Michael Houghton and Charles M Rice won the prize for the discovery of the virus that caused several deaths in the 1960s and …

Quicker detection of TB and hepatitis

Two new tests allow a faster and more accurate detection of tuberculosis and hepatitis B than possible earlier

Civil society challenges patents on Hepatitis C drugs

Pharmaceutical corporations obtain unjustified patents making the drugs unaffordable to many, petitioners claim  

Cheaper vaccine to check hepatitis B

WHO's immunisation programme is expected to receive a tremendous boost thanks to the low-cost vaccine developed through genetic engineering

Hepatitis in children: 2 new research focuses on probable causes

Their findings reveal it is likely a combination of 3 elements — co-infection with two different viruses and genetic susceptibility

Southeast Asia has a huge hepatitis burden—more than HIV and malaria combined

The region needs to enhance awareness and action to eliminate hepatitis, writes WHO regional director for southeast Asia s 

Gilead signs agreements with Indian generic companies for hepatitis C drug

Indian companies granted licence to produce generic sofosbuvir and investigational single tablet regimen of ledipasvir/sofosbuvir for treatment …

How liver protein can aid in developing vaccine for hepatitis C

More than 70 million globally are affected by chronic hepatitis C virus, increasing the risk for the more fatal liver cancer or cirrhosis

All about hepatitis

The government of India has included vaccine of hepatitis B in its vaccination programme but has paid scant attention to hepatitis C

Birth dose of hepatitis B vaccine may not be necessary: ICMR

Many newborns are protected from Hepatitis B infection by antibodies they receive from the mother and therefore, hepatitis B vaccination at birth …

Only 5 per cent of people infected with hepatitis B virus receive treatment

While 94 million people out of 292 million hepatitis B patients in 2016 were eligible for antiviral treatment, just 4.8 million got it, says a study

India’s role in increasing access to HCV drugs

Early intervention by the Indian government and civil society will be essential to overcome patent barriers to ensure that the new drugs …

Take Unani medicines seriously

HAKIM MOHAMMED KHALID SIDDIQUI, director of Central Council for Research in Unani Medicine, New Delhi, tells VIBHA VARSHNEY that …

Hepatitis C: India has failed to tackle the deadly disease

Chronic HCV infection accounts for 12-32 per cent of liver cancer and 10-20 per cent of cirrhosis cases in India. Most people with chronic …

Muted response

Hepatitis C is a growing problem in India, but government has no programme to manage the disease

‘Adenovirus is not new. Yet, we’ve never linked it with severe hepatitis’

Matthew R Vogt on link between acute flaccid myelitis & current acute paediatric hepatitis outbreak

What to do about Liberia's island colony of abandoned lab chimps?

These chimpanzees were intentionally infected with hepatitis and other pathogens to help develop a range of vaccines

Gilead expands hepatitis C licensing pacts with Indian companies

New programme introduces coercion and policing upon medical providers and may result in treatment interruptions for patients

COVID-19 : Why vaccinating children may be crucial

Vaccinating children will protect them against post-infectious conditions such as multisystem inflammatory syndrome; reduce risk of infection in …

UNICEF to procure controversial pentavalent vaccine at lowest-ever prices

This step will significantly increase the distribution of pentavalent vaccine, which has been blamed for adverse health effects

After India, China rejects patent claim for hepatitis C drug Sovaldi

Activists claim that the drug was developed using previously published information and an existing compound

New hepatitis drug to cost more in middle income nations; activists cry foul

Pharma company’s strategy of different prices for different countries to affect quality treatment of 185 million people infected with …